Objective: Clinical and pathological characteristics of triple negative breast cancer (TNBC) treatment are required for escalation or de-escalation of treatment because of a lack of druggable targets. This study aimed to identify the factors affecting the risk of disease recurrence and disease-related death in patients with TNBC.
Methods: Patients with TNBC who were treated at the University Medical Centre Maribor between January 2010 and December 2017 were studied.